Cara D Varley

Increasing multimorbidity burden after COVID-19 Infection Among People with and without HIV in the United States: Insights from the National Clinical Cohort Collaborative (N3C)

National Clinical Cohort Collaborative (N3C), Sandra E. Safo, Melissa A Haendel, Marlene Camacho‐Rivera et autres

People with HIV (PWH) have a disproportionately high burden of chronic comorbidities. However, how their multimorbidity patterns differ from those of the general population and how COVID-19 infection may affect this burden have not been well characterized. We conducted a retrospective cohort …

us (code pays fourni par la source)

Increasing multimorbidity burden after COVID-19 Infection Among People with and without HIV in the United States: Insights from the National Clinical Cohort Collaborative (N3C)

Yumeng Wang, Ahmed H. Sabit, Jerrod Anzalone, Dongmei Li et autres

Abstract Background People with HIV (PWH) have a disproportionately high burden of chronic comorbidities. However, how their multimorbidity patterns differ from those of the general population and how COVID-19 infection may affect this burden have not been well characterized. Methods We conducted …

us (code pays fourni par la source)

Racial, ethnic, and regional disparities in HIV testing during the COVID-19 pandemic in the USA: a nationwide, retrospective, observational study using National Clinical Cohort Collaborative data

Duolan Han, Jing Sun, Cara D Varley, Zachary Butzin-Dozier et autres

us (code pays fourni par la source)

Racial, ethnic, and regional disparities in HIV testing during the COVID-19 pandemic in the USA: a nationwide, retrospective, observational study using National Clinical Cohort Collaborative data

Haishan Yang, Duolan Han, Eric G. Hurwitz, Jerrod Anzalone et autres

us, ca (code pays fourni par la source)

HIV Status and COVID-19 Treatment Disparities in the US National Clinical Cohort Collaborative

Sandra E. Safo, Marlene Camacho‐Rivera, Emmanuel Nazaire Essam Nkodo, Nada A. Fadul et autres

In this retrospective N3C cohort study, persons with HIV and COVID-19 infection had significantly higher odds of receiving COVID-19 therapeutics than those without HIV. However, significant racial/ethnic inequities appeared, with a lower prevalence of COVID-19 therapeutics receipt among racial/ethnic minorities.

us (code pays fourni par la source)

P-1457. Vaccination trends for tetanus, hepatitis A, and hepatitis B in individuals with a substance use disorder, hospitalized at a United States integrated health care system, 2010 - 2023

Jennifer H Ku, Carolyn Hoke, Yuqian M. Gu, Hung Fu Tseng et autres

Abstract Background Individuals with substance use disorders (SUD) are at high risk for hepatitis A virus (HAV), hepatitis B virus (HBV), and tetanus infections. Hospitalizations are frequent for this population and may represent opportunities for preventive care, but data on vaccination trends …

us (code pays fourni par la source)

HIV Status and COVID-19 Treatment Disparities in the US National Clinical Cohort Collaborative

Emmanuel Nazaire Essam Nkodo, Pooja Maheria, Eric G. Hurwitz, Alfred Jerrod Anzalone et autres

Background: While disparities in COVID-19 therapeutic access have been documented, the effect of HIV status on treatment access and how it intersects with other sociodemographic factors has not been well explored. Using data from the National Clinical Cohort Collaborative (N3C), we investigated …

us (code pays fourni par la source)

Core outcome domains for Mycobacterium avium complex pulmonary disease: a MACCOR study

Cara D Varley, Sarah A. R. Siegel, Naomi A. DeBacker, Clifton O. Bingham et autres

Background: pulmonary disease (MAC-PD) is a chronic inflammatory disease with systemic manifestations affecting multiple aspects of patients' lives. Current microbiological outcome measures are often difficult to obtain and insufficient to reflect the impact of disease and treatment. We developed an international consensus-based …

us (code pays fourni par la source)

Screening and Vaccination Rates for Tetanus, Hepatitis A, and Hepatitis B Among Individuals With Substance Use Disorders Hospitalized in an Integrated US Health System

Jennifer H Ku, Yuqian M. Gu, Carolyn Hoke, Hung Fu Tseng et autres

BACKGROUND: Hepatitis A virus (HAV) infection, hepatitis B virus (HBV) infection, and tetanus are important vaccine-preventable infections among individuals with substance use disorder. Hospitalizations may represent opportunities for preventive care. Up-to-date data on screening and vaccination practices for this high-risk population are …

us (code pays fourni par la source)

Identifying People Living With or Those at Risk for HIV in a Nationally Sampled Electronic Health Record Repository Called the National Clinical Cohort Collaborative: Computational Phenotyping Study

Eric G. Hurwitz, Cara D Varley, Alfred Jerrod Anzalone, Vithal Madhira et autres

BACKGROUND: Electronic health records (EHRs) provide valuable insights to address clinical and epidemiological research concerning HIV, including the disproportionate impact of the COVID-19 pandemic on people living with HIV. To identify this population, most studies using EHR or claims databases start with …

us (code pays fourni par la source)

Outpatient Parenteral Antimicrobial Therapy Outcomes Metrics Assessment Survey

Jina T. Makadia, Amber C Streifel, Cara D Varley

We surveyed outpatient parenteral antimicrobial therapy team members to assess the importance of specific program metrics while eliciting collection barriers, which can guide establishing or restructuring programs. Several metrics were felt to be highly important but were not being collected by programs. …

us (code pays fourni par la source)

Hepatitis C Testing in the US Veterans Health Administration: Uptake of United States Preventive Services Taskforce Universal Hepatitis C Screening Guidance

Cara D Varley, Lauren A. Beste, Elliott Lowy, Timothy R.M. Morgan et autres

Background: Hepatitis C virus (HCV) is a risk factor for advanced liver disease and mortality; however, efficacious direct-acting antiviral therapy is available for those who are screened for and ultimately diagnosed with HCV, highlighting the importance of population-based screening. For nearly 25 …

us (code pays fourni par la source)